Literature DB >> 18369746

Neural differentiation of human embryonic stem cells.

Mirella Dottori1, Martin F Pera.   

Abstract

Embryonic stem cells (ESCs) are pluripotent and capable of indefinite self-renewal in vitro. These features make them a highly advantageous source for deriving any cell type of the central and peripheral nervous system. We describe neural induction of human (h)ESCs, by using the bone morphogenic protein inhibitor protein noggin. Neural progenitors derived from noggin-treated hESCs can be propagated as neurospheres and further differentiated in vitro and in vivo to mature neurons and glia. This complete protocol of neural differentiation, from hESCs to mature neuronal cells, can be used as an in vitro model to study human neurogenesis and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369746     DOI: 10.1007/978-1-59745-133-8_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

2.  Epigenetic therapy for Friedreich ataxia.

Authors:  Elisabetta Soragni; Wenyan Miao; Marco Iudicello; David Jacoby; Stefania De Mercanti; Marinella Clerico; Filomena Longo; Antonio Piga; Sherman Ku; Erica Campau; Jintang Du; Pablo Penalver; Myriam Rai; Joseph C Madara; Kristopher Nazor; Melinda O'Connor; Anton Maximov; Jeanne F Loring; Massimo Pandolfo; Luca Durelli; Joel M Gottesfeld; James R Rusche
Journal:  Ann Neurol       Date:  2014-09-16       Impact factor: 10.422

3.  Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells.

Authors:  Cherif Badja; Galyna Maleeva; Claire El-Yazidi; Emilie Barruet; Manon Lasserre; Philippe Tropel; Bernard Binetruy; Piotr Bregestovski; Frédérique Magdinier
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

4.  Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia.

Authors:  Yanjie Li; Urszula Polak; Angela D Bhalla; Natalia Rozwadowska; Jill Sergesketter Butler; David R Lynch; Sharon Y R Dent; Marek Napierala
Journal:  Mol Ther       Date:  2015-03-11       Impact factor: 11.454

5.  Mutations in DEPDC5 cause familial focal epilepsy with variable foci.

Authors:  Leanne M Dibbens; Boukje de Vries; Simona Donatello; Sarah E Heron; Bree L Hodgson; Satyan Chintawar; Douglas E Crompton; James N Hughes; Susannah T Bellows; Karl Martin Klein; Petra M C Callenbach; Mark A Corbett; Alison E Gardner; Sara Kivity; Xenia Iona; Brigid M Regan; Claudia M Weller; Denis Crimmins; Terence J O'Brien; Rosa Guerrero-López; John C Mulley; Francois Dubeau; Laura Licchetta; Francesca Bisulli; Patrick Cossette; Paul Q Thomas; Jozef Gecz; Jose Serratosa; Oebele F Brouwer; Frederick Andermann; Eva Andermann; Arn M J M van den Maagdenberg; Massimo Pandolfo; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Nat Genet       Date:  2013-03-31       Impact factor: 38.330

6.  Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival.

Authors:  Danhong Zhu; Xuemei Deng; Christine Spee; Shozo Sonoda; Chih-Lin Hsieh; Ernesto Barron; Martin Pera; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-01       Impact factor: 4.799

7.  Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.

Authors:  Urszula Polak; Yanjie Li; Jill Sergesketter Butler; Marek Napierala
Journal:  Stem Cells Dev       Date:  2016-10-17       Impact factor: 3.272

8.  Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.

Authors:  Jintang Du; Erica Campau; Elisabetta Soragni; Christine Jespersen; Joel M Gottesfeld
Journal:  Hum Mol Genet       Date:  2013-08-09       Impact factor: 6.150

Review 9.  Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.

Authors:  Detlev Boison
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

10.  Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres.

Authors:  Faten Zaibak; Paul Bello; Jennifer Kozlovski; Duncan Crombie; Haozhi Ang; Mirella Dottori; Robert Williamson
Journal:  BMC Biotechnol       Date:  2009-12-15       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.